CoChat

Steatohepatitis Impairs T-cell–Directed Immunotherapies Against Liver Tumors in Mice

Open access
Heinrich, Bernd, Brown, Zachary J., Diggs, Laurence P., Vormehr, Mathias, Ma, Chi, Subramanyam, Varun, Rosato, Umberto, Ruf, Benjamin, Walz, Juliane S., McVey, John C., Wabitsch, Simon, Fu, Qiong, Yu, Su Jong, Zhang, Qianfei, Lai, Chunwei W., Sahin, Ugur, Greten, Tim F. · 2021 · Gastroenterology
Cited by 82

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Background & Aims: Non-alcoholic steatohepatitis causes loss of hepatic CD4+ T cells and promotes tumor growth. The liver is the most common site of distant metastases from a variety of malignancies, many of which respond to immunotherapy. We investigated the effects of steatohepatitis on the efficacy of immunotherapeutic agents against liver tumors in mice. Methods: Steatohepatitis was induced by feeding C57BL/6NCrl or BALB/c AnNCr mice a methionine and choline-deficient diet (MCD) or a choline-deficient L-amino acid-defined diet (CDAA). Mice were given intrahepatic or subcutaneous injections of B16 melanoma and CT26 colon cancer cells, followed by given intravenous injections of mRNA vaccine (M30) or intraperitoneal injections of an antibody against OX40 (aOX40) on days 3, 7, and 10 after injection of the tumor cells. We measured tumor growth and analyzed immune cells in tumor tissues by flow cytometry. Mice were given N-acetylcysteine (NAC) to prevent loss of CD4+ T cells from liver. Results: Administration of M30 and aOX40 inhibited growth of tumors from intrahepatic injections of B16 or CT26 cells in mice on regular diet. However, M30 and/or aOX40 did not slow growth of liver tumors from B16 or CT26 cells in mice with diet-induced steatohepatitis (MCD or CDAA). Steatohepatitis did not affect the ability of M30 to slow growth of subcutaneous B16 tumors. In mice with steatohepatitis given NAC, which prevents loss of CD4+ T cells, M30 and aOX40 were able slow growth of hepatic tumors. Flow cytometry analysis of liver tumors revealed reduced CD4+ T cells and effector memory cells in mice with vs without steatohepatitis Conclusions: Steatohepatitis reduces the abilities of immunotherapeutic agents such as M30 and aOX40 to inhibit tumor liver growth by reducing tumor infiltration by CD4+ T cells and effector memory cells. NAC restores T-cell numbers in tumors and increases the ability of M30 and aOX40 to slow tumor growth in mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2020.09.031

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

Metadata

Authors
Heinrich, B., Brown, Z. J., Diggs, L. P., Vormehr, M., Ma, C., Subramanyam, V., Rosato, U., Ruf, B., Walz, J. S., McVey, J. C., Wabitsch, S., Fu, Q., Yu, S. J., Zhang, Q., Lai, C. W., Sahin, U., & Greten, T. F.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2021-01
Volume
160
Issue
1
Pages
331-345.e6
ISSN
0016-5085 (ISSN-L)
OpenAlex
W3090911118
Cited by
82
References
15
FWCI
4.09
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.